Apolipoprotein E gene polymorphisms and risk for coronary artery disease in Chinese Xinjiang Uygur and Han population

Sheng-Li Yang1, Bing-Xian He, Hui-Liang Liu

  • 1Department of Cardiology, General Hospital of Chinese People's Armed Police Forces, Beijing 100039. yangshengli@medmail.com.cn

Insights

The apolipoprotein E (Apo E) epsilon2 allele shows a protective effect against coronary artery disease (CAD), particularly in the Uygur population. Lower epsilon2 and higher epsilon3 or epsilon4 allele frequencies are observed in CAD patients.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Population Health

Background:

  • Apolipoprotein E (Apo E) gene polymorphism is implicated in cardiovascular health.
  • Understanding ethnic variations in Apo E allele frequencies is crucial for assessing coronary artery disease (CAD) risk.

Purpose of the Study:

  • To investigate the association between apolipoprotein E (Apo E) gene polymorphism and the risk of coronary artery disease (CAD).
  • To analyze the relationship between Apo E polymorphism and established cardiovascular risk factors.

Main Methods:

  • Prospective evaluation of 124 patients with verified CAD or myocardial infarction and 70 controls from Han and Uygur populations.
  • Genotyping of Apo E alleles (epsilon2, epsilon3, epsilon4) using PCR and HhaI digestion.
  • Assessment of classical risk factors including hypertension, diabetes, tobacco use, and lipid profiles (TC, HDL, TG, LDL).

Main Results:

  • Significant differences in Apo E allele frequencies were observed between Uygur and Han populations.
  • CAD patients exhibited lower frequencies of the epsilon2 allele and higher frequencies of epsilon3 or epsilon4 alleles compared to controls, especially in the Uygur group.
  • Apolipoprotein E (Apo E) phenotypes E2/2, E3/2, and E4/2 showed a trend towards decreased serum lipid levels (LDL, TC, TG).

Conclusions:

  • Apolipoprotein E (Apo E) phenotype distribution varies significantly between Uygur and Han populations.
  • The epsilon2 allele of the apolipoprotein E (Apo E) gene demonstrates a protective effect against coronary artery disease (CAD).
  • Elevated frequencies of epsilon3 and epsilon4 alleles in CAD patients suggest their association with increased disease risk.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...